Ana Micaela Martins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Micaela Martins has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Ribeiro Alves
Internal Medicine Service, Local Health Unit of the Aveiro Region, Aveiro, Portugal
1 shared publication - Joana Martinez
Infectious Diseases Service, Local Health Unit of the Aveiro Region, Aveiro, Portugal
1 shared publication - João Fonseca
Internal Medicine Service, Local Health Unit of the Aveiro Region, Aveiro, Portugal
1 shared publication Mónica Mata
Internal Medicine Service, Local Health Unit of the Aveiro Region, Aveiro, Portugal
1 shared publication- Paula Mesquita
Internal Medicine Service, Local Health Unit of the Aveiro Region, Aveiro, Portugal
1 shared publication
Latest Publications
- Open Access
- 22 October 2025
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 12 (11)
Disseminated cryptococcosis: a diagnostic challenge in an immunocompromised patient
Background: Cryptococcosis is an opportunistic fungal infection that causes disseminated disease in immunocompromised patients. Peritoneal involvement is rare and diagnostically challenging. Case report: A 76-year-old man with Crohn’s disease on infliximab and previously treated latent tuberculosis was admitted with constitutional symptoms and abdominal distention evolving over 5 months. Ultrasound revealed bilateral pleural effusion and ascites. Initial hypotheses—peritoneal carcinomatosis and tuberculosis—were excluded through computed tomography scan, laboratory tests, and exploratory laparoscopy with biopsy, which showed necrotizing granulomatous peritonitis. Disseminated cryptococcosis was confirmed by India ink staining, cultures from peritoneal and pleural fluids, and serum cryptococcal antigen. Cerebrospinal fluid analysis and ophthalmological evaluation excluded central nervous system and ocular involvement. Treatment with liposomal amphotericin B and flucytosine led to clinical improvement. Conclusion: This case highlights the importance of considering cryptococcosis in the differential diagnosis of polyserositis in immunocompromised patients. Early diagnosis and antifungal therapy improve outcomes.
- 22 October 2025
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 12 (11)
Open AccessDisseminated cryptococcosis: a diagnostic challenge in an immunocompromised patient
Background: Cryptococcosis is an opportunistic fungal infection that causes disseminated disease in immunocompromised patients. Peritoneal involvement is rare and diagnostically challenging. Case report: A 76-year-old man with Crohn’s disease on infliximab and previously treated latent tuberculosis was admitted with constitutional symptoms and abdominal distention evolving over 5 months. Ultrasound revealed bilateral pleural effusion and ascites. Initial hypotheses—peritoneal carcinomatosis and tuberculosis—were excluded through computed tomography scan, laboratory tests, and exploratory laparoscopy with biopsy, which showed necrotizing granulomatous peritonitis. Disseminated cryptococcosis was confirmed by India ink staining, cultures from peritoneal and pleural fluids, and serum cryptococcal antigen. Cerebrospinal fluid analysis and ophthalmological evaluation excluded central nervous system and ocular involvement. Treatment with liposomal amphotericin B and flucytosine led to clinical improvement. Conclusion: This case highlights the importance of considering cryptococcosis in the differential diagnosis of polyserositis in immunocompromised patients. Early diagnosis and antifungal therapy improve outcomes.